Detalhe da pesquisa
1.
Combined BRAF, MEK, and heat-shock protein 90 inhibition in advanced BRAF V600-mutant melanoma.
Cancer
; 130(2): 232-243, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776537
2.
Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.
Support Care Cancer
; 32(6): 330, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709312
3.
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
Cancer
; 129(11): 1723-1734, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869646
4.
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Lancet
; 400(10357): 1008-1019, 2022 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108657
5.
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma.
Mol Ther
; 30(6): 2315-2326, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150889
6.
spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data.
Bioinformatics
; 37(23): 4584-4586, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34734969
7.
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model.
Cancer Immunol Immunother
; 69(12): 2465-2476, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556443
8.
The role of nitric oxide in melanoma.
Biochim Biophys Acta Rev Cancer
; 1868(2): 500-509, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28963068
9.
Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy.
World J Surg
; 44(4): 1283-1293, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811340
10.
Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma.
J Surg Oncol
; 118(3): 501-509, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132912
11.
A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.
J Immunol
; 197(4): 1489-97, 2016 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27385779
12.
MicroRNA-3151 inactivates TP53 in BRAF-mutated human malignancies.
Proc Natl Acad Sci U S A
; 112(49): E6744-51, 2015 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26582795
13.
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer.
Cancer Immunol Immunother
; 66(11): 1437-1447, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28688082
14.
The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells.
J Immunol
; 195(5): 1995-2005, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26238487
15.
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation.
Proc Natl Acad Sci U S A
; 111(11): 4179-84, 2014 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24586049
16.
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease.
Cancer Immunol Immunother
; 64(2): 149-59, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25305035
17.
Review of S100A9 biology and its role in cancer.
Biochim Biophys Acta
; 1835(1): 100-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23123827
18.
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.
Cancer Immunol Immunother
; 68(4): 619-629, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30725205
19.
Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide.
Biopolymers
; 102(4): 344-58, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839139
20.
A metabolic perspective on nitric oxide function in melanoma.
Biochim Biophys Acta Rev Cancer
; 1879(1): 189038, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061664